Catalyst Pharmaceuticals Inc (CPRX)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 195,124 173,973 85,876 78,329 86,812 75,921 138,211 120,081 101,838 83,779 72,681 59,950 52,385 48,261 45,961 40,405 41,304 40,693 42,834 43,511
Revenue (ttm) US$ in thousands 491,734 460,482 434,475 411,347 398,204 348,393 302,949 256,480 214,203 191,755 170,465 153,717 140,833 133,539 126,902 120,142 119,073 118,181 119,761 118,994
Operating profit margin 39.68% 37.78% 19.77% 19.04% 21.80% 21.79% 45.62% 46.82% 47.54% 43.69% 42.64% 39.00% 37.20% 36.14% 36.22% 33.63% 34.69% 34.43% 35.77% 36.57%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $195,124K ÷ $491,734K
= 39.68%

Catalyst Pharmaceuticals Inc's operating profit margin has shown fluctuations over the analyzed period. The margin was relatively stable in the range of 34% to 36% from March 31, 2020, to June 30, 2021. Thereafter, there was a significant increase to 42.64% by June 30, 2022, followed by a continuous increasing trend, reaching a peak of 47.54% by December 31, 2022.

However, there was a notable decline in the operating profit margin in the subsequent quarters, dropping to 19.04% by March 31, 2024. The margin slightly recovered to 39.68% by December 31, 2024.

The operating profit margin is a key indicator of a company's operational efficiency and profitability, reflecting the proportion of revenue that translates into operating income. The fluctuations observed in Catalyst Pharmaceuticals Inc's operating profit margin highlight the company's ability to manage costs and generate profits from its core operations. Further analysis and consideration of the company's financial performance and business strategies would be necessary to fully evaluate the implications of these fluctuations.